Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala

被引:26
|
作者
Tschritter, O [1 ]
Fritsche, A [1 ]
Stefan, N [1 ]
Haap, M [1 ]
Thamer, C [1 ]
Bachmann, O [1 ]
Dahl, D [1 ]
Maerker, E [1 ]
Teigeler, A [1 ]
Machicao, F [1 ]
Häring, H [1 ]
Stumvoll, M [1 ]
机构
[1] Univ Tubingen, Med Klin, Abt Endokrinol Stoffwechsel & Pathochem, D-72076 Tubingen, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 06期
关键词
D O I
10.1016/S0026-0495(03)00071-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPARgamma2) is associated with reduced risk for type 2 diabetes. Although increased insulin sensitivity of glucose disposal and lipolysis has been reported, the exact mechanism by which the risk reduction is conferred is not clear. Because the conclusion of greater insulin sensitivity hinged upon lower insulin levels in some studies, it is possible that more efficient insulin clearance is involved. We therefore estimated insulin clearance during a euglycemic hyperinsulinemic clamp (insulin infusion rate divided by steady-state insulin concentration, 229 normal glucose tolerant [NGT] subjects), an oral glucose tolerance test (OGTT) (mean C-peptide divided by mean insulin concentrations, 406 NGT, 54 impaired glucose tolerant or mildly diabetic subjects), and a hyperglycemic clamp (120 minutes, 10 mmol/L, C-peptide divided by insulin in the steady-state, 56 NGT subjects). In the carriers of the Ala allele (prevalence similar to24%), insulin clearance in all 3 protocols was significantly greater (similar to 10%), than in controls. While the results from the euglycemic clamp reflect both hepatic and peripheral insulin clearance; those from the OGTT and the hyperglycemic clamp reflect mainly hepatic insulin extraction. Free fatty acids (FFA) during the steady state of the euglycemic hyperinsulinemic clamp were significantly lower in carriers of the Ala allele (26 +/- 5 mumol/L) than in controls (46 +/- 3 mumol/L, P = .02). In conclusion, the Pro12Ala polymorphism is associated with increased insulin clearance. This could be the result of reduced FFA delivery, which has been shown to improve hepatic insulin removal and sensitivity. Because PPARgamma2 is mainly expressed in adipose tissue, one of the main regulatory effects of the polymorphism may well be the more efficient suppression of (possibly intra-abdominal) lipolysis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 50 条
  • [41] Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-gamma (PPARγ) Gene in Inflammatory Bowel Disease
    Atug, Ozlen
    Tahan, Veysel
    Eren, Fatih
    Tiftikci, Arzu
    Imeryuz, Nese
    Hamzaoglu, Hulya Over
    Tozun, Nurdan
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2008, 17 (04) : 433 - 437
  • [42] Does peroxisome proliferator-activated receptor γ genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks, PW
    Luan, J
    Browne, PO
    Harding, AH
    O'Rahilly, S
    Chatterjee, VKK
    Wareham, NJ
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (01): : 11 - 16
  • [43] The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gene is associated with decreased insulin secretion after elevation of free fatty acids
    Stefan, N
    Fritsche, A
    Häring, H
    Stumvoll, M
    DIABETOLOGIA, 2000, 43 : A51 - A51
  • [44] Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population
    Zhou, Tian-Biao
    Guo, Xue-Feng
    Yin, Sheng-Sheng
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2014, 34 (03) : 180 - 184
  • [45] Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese
    Lei, HH
    Chen, MH
    Yang, WS
    Chiu, MC
    Chen, MC
    Tai, TY
    Chuang, LM
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (10): : 1267 - 1270
  • [46] The protective effect of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) isoform 2 in progression to diabetes in a Pakistani cohort
    Khushbakht
    Sarwar, Sumbal
    Shabana
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2018, 38 (02) : 238 - 242
  • [47] EFFECT OF THE Pro12Ala POLYMORPHISM OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORγ2 GENE ON LIPID PROFILE AND ADIPOKINES LEVELS IN OBESE SUBJECTS
    Becer, E.
    Cirakoglu, A.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2017, 20 (01) : 71 - 79
  • [48] The peroxisome proliferator-activated receptor γ2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose
    Li, WD
    Lee, JH
    Price, RA
    MOLECULAR GENETICS AND METABOLISM, 2000, 70 (02) : 159 - 161
  • [49] Peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes
    Stene, Lars C.
    Thorsby, Per M.
    Berg, Jens P.
    Ronningen, Kjersti S.
    Joner, Geir
    PEDIATRIC DIABETES, 2008, 9 (01) : 40 - 45
  • [50] Effects of peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism on body fat distribution in female Korean subjects
    Kim, KS
    Choi, SM
    Shin, SU
    Yang, HS
    Yoon, Y
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (12): : 1538 - 1543